179 related articles for article (PubMed ID: 2227106)
1. Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate.
Brichard SM; Bailey CJ; Henquin JC
Diabetes; 1990 Nov; 39(11):1326-32. PubMed ID: 2227106
[TBL] [Abstract][Full Text] [Related]
2. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats.
Brichard SM; Okitolonda W; Henquin JC
Endocrinology; 1988 Oct; 123(4):2048-53. PubMed ID: 3046930
[TBL] [Abstract][Full Text] [Related]
3. Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats.
Brichard SM; Pottier AM; Henquin JC
Endocrinology; 1989 Nov; 125(5):2510-6. PubMed ID: 2676485
[TBL] [Abstract][Full Text] [Related]
4. In vivo insulin resistance in streptozotocin-diabetic rats--evidence for reversal following oral vanadate treatment.
Blondel O; Bailbe D; Portha B
Diabetologia; 1989 Mar; 32(3):185-90. PubMed ID: 2666209
[TBL] [Abstract][Full Text] [Related]
5. Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.
Meyerovitch J; Rothenberg P; Shechter Y; Bonner-Weir S; Kahn CR
J Clin Invest; 1991 Apr; 87(4):1286-94. PubMed ID: 1707061
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
7. Insulinlike effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats.
Pugazhenthi S; Khandelwal RL
Diabetes; 1990 Jul; 39(7):821-7. PubMed ID: 2113014
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
9. Improvement of mild hypoinsulinaemic diabetes in the rat by low non-toxic doses of vanadate.
Henquin JC; Carton F; Ongemba LN; Becker DJ
J Endocrinol; 1994 Sep; 142(3):555-61. PubMed ID: 7964305
[TBL] [Abstract][Full Text] [Related]
10. The influence of vanadate on insulin counter-regulatory hormones in obese fa/fa rats.
Brichard SM; Ongemba LN; Kolanowski J; Henquin JC
J Endocrinol; 1991 Nov; 131(2):185-91. PubMed ID: 1744566
[TBL] [Abstract][Full Text] [Related]
11. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
Rossetti L; Lauglin MR
J Clin Invest; 1989 Sep; 84(3):892-9. PubMed ID: 2503545
[TBL] [Abstract][Full Text] [Related]
12. Oral vanadate decreases muscle insulin resistance in obese fa/fa rats.
Brichard SM; Ongemba LN; Henquin JC
Diabetologia; 1992 Jun; 35(6):522-7. PubMed ID: 1612224
[TBL] [Abstract][Full Text] [Related]
13. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
14. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
Blondel O; Simon J; Chevalier B; Portha B
Am J Physiol; 1990 Mar; 258(3 Pt 1):E459-67. PubMed ID: 2180315
[TBL] [Abstract][Full Text] [Related]
15. MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Bhattacharjee A; Allister EM; Wheeler MB
Can J Physiol Pharmacol; 2012 May; 90(5):663-8. PubMed ID: 22530993
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice.
Pugazhenthi S; Angel JF; Khandelwal RL
Metabolism; 1991 Sep; 40(9):941-6. PubMed ID: 1910143
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingström G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Björkstrand E; Abrahmsen LB
Endocrinology; 2003 Nov; 144(11):4755-62. PubMed ID: 12960099
[TBL] [Abstract][Full Text] [Related]
18. Vanadate normalizes hyperglycemia and phosphoenolpyruvate carboxykinase mRNA levels in ob/ob mice.
Ferber S; Meyerovitch J; Kriauciunas KM; Kahn CR
Metabolism; 1994 Nov; 43(11):1346-54. PubMed ID: 7968588
[TBL] [Abstract][Full Text] [Related]
19. Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism.
Sun Q; Sekar N; Goldwaser I; Gershonov E; Fridkin M; Shechter Y
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E403-10. PubMed ID: 10913041
[TBL] [Abstract][Full Text] [Related]
20. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
